See also this year's filing and all EDGAR filings for this company.
PDF Report 0001107421_2013_Alaunos_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001107421', 'EntityCommonStockSharesOutstanding': 83696029, 'Assets': 71754000, 'AssetsCurrent': 70297000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 22371000, 'LiabilitiesAndStockholdersEquity': 71754000, 'LiabilitiesCurrent': 7791000, 'LiabilitiesNoncurrent': 20000, 'NetIncome': -57107000, 'PropertyPlantAndEquipmentNet': 801000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 656000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 14560000, 'remainder_LiabilitiesAndStockholdersEquity': 49383000, 'remainder_NetIncome': -57107000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0001107421, Alaunos Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 80,276,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,994,000 |
| 3 | remainder_Assets | 1,134,000 |
| 4 | LiabilitiesCurrent | 18,864,000 |
| 5 | LiabilitiesNoncurrent | 12,962,000 |
| 6 | remainder_Liabilities | 3,133,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 88,318,000 |
| 9 | ResearchAndDevelopmentExpense | 212,345,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,467,000 |
| 12 | remainder_NetIncome | 15,472,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 83,404,000 |
| 1 | Liabilities | 34,959,000 |
| 2 | Expenses | 300,663,000 |
| 3 | Revenues | 1,467,000 |
| 4 | StockholdersEquity | 48,445,000 |
| 5 | NetIncome | -283,724,000 |
| 6 | ComprehensiveNetIncome | -283,724,000 |
| 7 | BaseVar | 217,982,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.01 |
| 9 | EconomicCapitalRatio | 0.683 |
Edgar->Model Mapping
Feature Distribution
Change over Time
